KENVUE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.3 USD | +1.63% |
|
-0.26% | -10.36% |
| May. 23 | Some of the biggest splits in Corporate America | RE |
| May. 22 | Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies | RE |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 41,230 | 36,956 | - | - |
| Enterprise Value (EV) 1 | 48,130 | 43,890 | 43,335 | 42,482 |
| P/E ratio | 23.9 x | 21.6 x | 17.7 x | 16.6 x |
| Yield | 1.86% | 4.01% | 4.23% | 4.42% |
| Capitalization / Revenue | 2.67 x | 2.36 x | 2.28 x | 2.21 x |
| EV / Revenue | 3.12 x | 2.8 x | 2.67 x | 2.54 x |
| EV / EBITDA | 13 x | 11.7 x | 10.8 x | 10.1 x |
| EV / FCF | 17.8 x | 24.1 x | 18.5 x | 16.1 x |
| FCF Yield | 5.61% | 4.14% | 5.42% | 6.22% |
| Price to Book | 3.68 x | 3.34 x | 3.2 x | 2.99 x |
| Nbr of stocks (in thousands) | 1,914,995 | 1,914,815 | - | - |
| Reference price 2 | 21.53 | 19.30 | 19.30 | 19.30 |
| Announcement Date | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | 14,950 | 15,444 | 15,685 | 16,224 | 16,741 |
| EBITDA 1 | - | 3,697 | 3,737 | 4,012 | 4,219 |
| EBIT 1 | - | 3,457 | 3,409 | 3,556 | 3,697 |
| Operating Margin | - | 22.38% | 21.73% | 21.92% | 22.08% |
| Earnings before Tax (EBT) 1 | - | 2,190 | 2,122 | 2,734 | 2,948 |
| Net income 1 | 2,087 | 1,664 | 1,709 | 2,077 | 2,222 |
| Net margin | 13.96% | 10.77% | 10.9% | 12.8% | 13.27% |
| EPS 2 | - | 0.9000 | 0.8934 | 1.088 | 1.161 |
| Free Cash Flow 1 | - | 2,700 | 1,818 | 2,348 | 2,644 |
| FCF margin | - | 17.48% | 11.59% | 14.47% | 15.79% |
| FCF Conversion (EBITDA) | - | 73.03% | 48.65% | 58.53% | 62.67% |
| FCF Conversion (Net income) | - | 162.26% | 106.38% | 113.09% | 118.97% |
| Dividend per Share 2 | - | 0.4000 | 0.7737 | 0.8166 | 0.8525 |
| Announcement Date | 3/3/23 | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,011 | 3,915 | 3,666 | 3,894 | 3,970 | 4,007 | 3,829 | 4,039 | 4,109 |
| EBITDA 1 | 983 | 961 | 886 | 933 | 943.8 | 983.2 | 927.6 | 1,026 | 1,038 |
| EBIT 1 | 885 | 914 | 799 | 855 | 854.4 | 878 | 820 | 882.3 | 903.1 |
| Operating Margin | 22.06% | 23.35% | 21.79% | 21.96% | 21.52% | 21.91% | 21.42% | 21.84% | 21.98% |
| Earnings before Tax (EBT) 1 | 639 | 585 | 357 | 427 | 598.7 | 586.1 | 549.5 | 645.2 | 676.5 |
| Net income 1 | 430 | 438 | 327 | 296 | 454.4 | 456.9 | 436.9 | 547.9 | 482.3 |
| Net margin | 10.72% | 11.19% | 8.92% | 7.6% | 11.44% | 11.4% | 11.41% | 13.56% | 11.74% |
| EPS 2 | 0.2300 | 0.2300 | 0.1700 | 0.1500 | 0.2485 | 0.2575 | 0.2426 | 0.2728 | 0.2631 |
| Dividend per Share 2 | - | 0.2000 | 0.2000 | 0.2000 | 0.2001 | 0.1986 | 0.1936 | 0.1932 | 0.1931 |
| Announcement Date | 7/20/23 | 10/26/23 | 2/8/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 6,900 | 6,934 | 6,379 | 5,526 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.866 x | 1.856 x | 1.59 x | 1.31 x |
| Free Cash Flow 1 | - | 2,700 | 1,818 | 2,348 | 2,644 |
| ROE (net income / shareholders' equity) | - | 15.3% | 19.8% | 20.8% | 20.6% |
| ROA (Net income/ Total Assets) | - | 8.64% | 6.24% | 7.55% | 8.33% |
| Assets 1 | - | 19,261 | 27,381 | 27,520 | 26,663 |
| Book Value Per Share 2 | - | 5.850 | 5.790 | 6.040 | 6.450 |
| Cash Flow per Share 2 | - | 1.730 | 1.180 | 1.490 | 1.640 |
| Capex 1 | - | 500 | 496 | 496 | 494 |
| Capex / Sales | - | 3.24% | 3.16% | 3.06% | 2.95% |
| Announcement Date | 3/3/23 | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
19.3
USD
Average target price
22.54
USD
Spread / Average Target
+16.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.36% | 36.96B | |
| +12.28% | 388B | |
| +12.61% | 136B | |
| +16.62% | 76.27B | |
| -12.57% | 65.56B | |
| -15.65% | 44.23B | |
| +6.37% | 35.04B | |
| +7.80% | 18.02B | |
| +12.30% | 15.57B | |
| -2.17% | 11.58B |
- Stock Market
- Equities
- KVUE Stock
- Financials Kenvue Inc.
